CO5280140A1 - Antigeno (c42) asociado a tumores - Google Patents

Antigeno (c42) asociado a tumores

Info

Publication number
CO5280140A1
CO5280140A1 CO00038722A CO00038722A CO5280140A1 CO 5280140 A1 CO5280140 A1 CO 5280140A1 CO 00038722 A CO00038722 A CO 00038722A CO 00038722 A CO00038722 A CO 00038722A CO 5280140 A1 CO5280140 A1 CO 5280140A1
Authority
CO
Colombia
Prior art keywords
antigen
tumors
elicits
designation
tumor
Prior art date
Application number
CO00038722A
Other languages
English (en)
Inventor
Adolf Guenther
Ulrich Koenig
Wolfgang Sommergruber
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5280140A1 publication Critical patent/CO5280140A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

Antígeno asociado a un tumor con la denominación C42, caracterizado porque contiene la secuencia de aminoácidos definida en SEQ ID. NO:2. (Poli)péptido inmunógeno según la reivindicación 1 o 2, que provoca una respuesta inmunitaria celular.
CO00038722A 1999-05-27 2000-05-25 Antigeno (c42) asociado a tumores CO5280140A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924199A DE19924199A1 (de) 1999-05-27 1999-05-27 Tumorassoziiertes Antigen

Publications (1)

Publication Number Publication Date
CO5280140A1 true CO5280140A1 (es) 2003-05-30

Family

ID=7909293

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00038722A CO5280140A1 (es) 1999-05-27 2000-05-25 Antigeno (c42) asociado a tumores

Country Status (10)

Country Link
EP (1) EP1183349A1 (es)
JP (1) JP2003501025A (es)
AR (1) AR024114A1 (es)
AU (1) AU4924000A (es)
CA (1) CA2376133A1 (es)
CO (1) CO5280140A1 (es)
DE (1) DE19924199A1 (es)
MX (1) MXPA01012012A (es)
UY (1) UY26170A1 (es)
WO (1) WO2000073438A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7141365B2 (en) * 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
CN1313617C (zh) 2001-11-07 2007-05-02 曼康公司 编码靶相关抗原表位的表达载体及其设计方法
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE102005041616B4 (de) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1299414A (zh) * 1998-03-18 2001-06-13 科里克萨有限公司 用于治疗和诊断肺癌的化合物和方法
WO2000012711A2 (en) * 1998-09-02 2000-03-09 Incyte Pharmaceuticals, Inc. Human membrane channel proteins

Also Published As

Publication number Publication date
WO2000073438A1 (de) 2000-12-07
AU4924000A (en) 2000-12-18
AR024114A1 (es) 2002-09-04
EP1183349A1 (de) 2002-03-06
UY26170A1 (es) 2000-12-29
JP2003501025A (ja) 2003-01-14
MXPA01012012A (es) 2002-06-21
DE19924199A1 (de) 2000-11-30
CA2376133A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
CY1109978T1 (el) Αντιγονικα πεπτιδια εξαγομενα απο τελομεραση
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
WO2002018424A3 (en) Nucleic acids and polypeptides
CO5280140A1 (es) Antigeno (c42) asociado a tumores
ATE316577T1 (de) Das goodpasture-antigen bindende protein
WO2001079449A3 (en) Novel nucleic acids and polypeptides
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NZ515041A (en) Nucleic acid immunization
WO2000012122A3 (de) Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen

Legal Events

Date Code Title Description
FA Application withdrawn